Ohkuchi, A., Hirashima, C., Matsunara, S., Suzuki, H., Takahashi, H., Arai, F., et al. (2007) Alterations in Placental Growth Factor Levels before and after the Onset of Preeclampsia are More Pronounced in Women with Early-Onset Severe Preeclampsia. Hypertension Research, 30, 151-159.
http://dx.doi.org/10.1291/hypres.30.151

has been cited by the following article:

• TITLE: The Level of Soluble FMS-Like Tyrosinkinase-1, Placental Growth Factor and Vitamin E in Pre-Eclampsia and Normotensive Pregnancy

  AUTHORS: John Wantania, Meilany Durry, Janno Bernadus

  KEYWORDS: sFlt-1, PlGF, Vitamin E, Pre-Eclampsia, Normotensive Pregnancies

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.7, July 10, 2015

  ABSTRACT: Background: This study aims to determine the differences of angiogenic markers sFlt-1 (soluble FMS-like tyrosine kinase-1), Placental Growth Factor (PlGF) and antioxidant (vitamin E) levels in pre-eclampsia compared with normotensive pregnancies. Methods: In a cross-sectional study performed on 40 normotensive pregnancies and 40 pre-eclampsia women, serum levels of sFlt-1, PlGF and vitamin E were measured with ELISA methods. Statistical analysis used Mann Whitney. Results: The serum levels from the group of normotensive pregnancy and pre-eclampsia women consecutively are as follows: sFlt-1 2251.32 ± 416.17 pg/mL and 2950.78 ± 221.34 pg/mL, having a very significant difference (p = 0.00); PlGF 391.67 ± 293.92 pg/mL and 150.15 ± 105.34 pg/mL, having a very significant difference; vitamin E 8537.21 ± 6299.74 unit and 700.61 ± 233.70 unit, having a very significant difference. Conclusion: There is a very significant difference between an-giogenic markers and antioxidant levels in pre-eclampsia and normotensive pregnancies.